1h Free Analyst Time
The publisher's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer - Drugs In Development, 2022, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.Speak directly to the analyst to clarify any post sales queries you may have.
Colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers begin as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools and weight loss with no known reason. Risk factors include smoking, heavy alcohol use, inflammatory bowel disease (IBD) and family history. Treatment includes surgery, radiation therapy and chemotherapy.
Report Highlights
The publisher's Pharmaceutical and Healthcare latest pipeline guide Colorectal Cancer - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Colorectal Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Colorectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Colorectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 13, 179, 246, 4, 35, 376, 91 and 8 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages comprises 1, 15, 20, 2, 1, 35, 6 and 1 molecules, respectively.
Colorectal Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Colorectal Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Colorectal Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Colorectal Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Colorectal Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Colorectal Cancer (Oncology)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Colorectal Cancer (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Colorectal Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
- Introduction
- Report Coverage
- Colorectal Cancer - Overview
- Colorectal Cancer - Therapeutics Development
- Pipeline Overview
- Pipeline by Companies
- Pipeline by Universities/Institutes
- Products under Development by Companies
- Products under Development by Universities/Institutes
- Colorectal Cancer - Therapeutics Assessment
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
- Colorectal Cancer - Companies Involved in Therapeutics Development
- Colorectal Cancer - Drug Profiles
- Colorectal Cancer - Dormant Projects
- Colorectal Cancer - Discontinued Products
- Colorectal Cancer - Product Development Milestones
- Featured News & Press Releases
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact the Publisher
- Disclaimer
- Number of Products under Development for Colorectal Cancer, 2022
- Number of Products under Development by Companies, 2022
- Number of Products under Development by Universities/Institutes, 2022
- Products under Development by Companies, 2022
- Products under Development by Universities/Institutes, 2022
- Number of Products by Stage and Target, 2022
- Number of Products by Stage and Mechanism of Action, 2022
- Number of Products by Stage and Route of Administration, 2022
- Number of Products by Stage and Molecule Type, 2022
- Colorectal Cancer - Dormant Projects, 2022
- Colorectal Cancer - Discontinued Products, 2022
- Number of Products under Development for Colorectal Cancer, 2022
- Number of Products under Development by Companies, 2022
- Number of Products by Top 10 Targets, 2022
- Number of Products by Stage and Top 10 Targets, 2022
- Number of Products by Top 10 Mechanism of Actions, 2022
- Number of Products by Stage and Top 10 Mechanism of Actions, 2022
- Number of Products by Stage and Top 10 Routes of Administration, 2022
- Number of Products by Top 10 Molecule Types, 2022
- Number of Products by Stage and Top 10 Molecule Types, 2022
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3B Pharmaceuticals GmbH
- 3SBio Inc
- 4D Pharma Plc
- 4SC AG
- A2 Biotherapeutics Inc
- AB Pharma Ltd
- AbbVie Inc
- Abclon Inc
- Abcuro Inc
- ABL Bio Inc
- ABM Therapeutics Inc
- Abtlas
- AC Bioscience SA
- AcadeMab Biomedical Inc
- Aclaris Therapeutics Inc
- Adagene Suzhou Ltd
- Adamed Pharma SA
- ADC Therapeutics SA
- Adlai Nortye Biopharma Co Ltd
- ADT Pharmaceuticals Inc
- Advanced Accelerator Applications SA
- Advanced BioDesign
- Advaxis Inc
- Advenchen Laboratories LLC
- Affimed GmbH
- Agenus Inc
- Agilvax Inc
- AI Therapeutics Inc
- Aileron Therapeutics Inc
- AilseVax Ltd
- Akeso Inc
- Aktis Oncology Inc
- Alfasigma SpA
- Alkermes Plc
- Alligator Bioscience AB
- Allinky Biopharma SL
- Allist Shanghai Pharmaceutical Technology Co Ltd
- Almac Discovery Ltd
- AlphaMab Co Ltd
- Alphamab Oncology
- AlphaVax Inc
- Alpine Immune Sciences Inc
- Altamira Therapeutics Ltd
- Altimmune Inc
- AltruBio Inc
- Amarin Corp Plc
- Ambrx Biopharma Inc
- amcure GmbH
- Amgen Inc
- Amitech Therapeutic Solutions Inc
- AmMax Bio Inc
- Amphivena Therapeutics Inc
- Amrita Therapeutics
- Amunix Operating Inc
- Anaveon AG
- Andes Biotechnologies
- Angex Pharmaceutical Inc
- AnHeart Therapeutics Inc
- Anhorn Medicines Co Ltd
- Ansun Biopharma Inc
- Apcegen Technologies Pvt Ltd
- Apexian Pharmaceuticals Inc
- Apexigen Inc
- Aphios Corp
- Apmonia Therapeutics SAS
- Apogenix AG
- Apollomics Inc
- Applied Research using OMIC Sciences SL
- Aprogen Inc
- Apros Therapeutics Inc
- Aptorum Group Ltd
- Arbele Ltd
- Argonaut Therapeutics Ltd
- Arum Therapeutics Inc
- Arvinas Inc
- Asana BioSciences LLC
- Ascenta Therapeutics Inc
- Ascentage Pharma Group International
- Ascentawits Pharmaceuticals Ltd
- Aslan Pharmaceuticals Ltd
- Astellas Pharma Inc
- AstraZeneca Plc
- Atreca Inc
- Aucentra Therapeutics Pty Ltd
- Aulos Bioscience Inc
- Aurigene Discovery Technologies Ltd
- Avacta Life Sciences Ltd
- Avesthagen Ltd
- Avicenna Therapeutics Inc
- B Cell Design SAS
- Bantam Pharmaceutical LLC
- Baobab AiBIO Co Ltd
- Barricade Therapeutics Corp
- Basilea Pharmaceutica Ltd
- Bavarian Nordic AS
- Bayer AG
- BeiGene Ltd
- Beijing BGI-GBI Biotech Co Ltd
- Beijing Corregene Biotechnology Co Ltd
- Beijing Eastern Biotech Co Ltd
- Beijing Mabworks Biotech Co Ltd
- Beijing Scitech-MQ Pharmaceuticals Ltd
- Beijing Tricision Biotherapeutics Inc
- Betta Pharmaceuticals Co Ltd
- Bexion Pharmaceuticals LLC
- Bicara Therapeutics Inc
- Bicycle Therapeutics Plc
- BIMINI Biotech BV
- Bio4t2 LLC
- BioAtla Inc
- Biocad
- BioCurity Pharmaceuticals Inc
- BioEclipse Therapeutics Inc
- BioMed Valley Discoveries Inc
- BioNTech SE
- Biosceptre International Ltd
- Biosion Inc
- Biosplice Therapeutics Inc
- BioSyngen Pte Ltd
- Biotheus Inc
- BioVaxys Technology Corp
- Bioviz Technologies Pvt Ltd
- BioXcel Therapeutics Inc
- bitBiome Co Ltd
- bluebird bio Inc
- Blueprint Medicines Corp
- Boehringer Ingelheim International GmbH
- Bold Therapeutics Inc
- Bolt Biotherapeutics Inc
- BreakBio Corp
- BriaCell Therapeutics Corp
- BridgeBio Pharma Inc
- BrightGene Bio-Medical Technology Co Ltd
- Bristol-Myers Squibb Co
- Bromodomain Pharmaceuticals Inc
- C4 Therapeutics Inc
- C4X Discovery Holdings Plc
- Calithera Biosciences Inc
- Cancer Advances Inc
- Cancer Therapeutics Laboratories Inc
- Canget BioTekpharma LLC
- Cantargia AB
- Captor Therapeutics SA
- Cardiff Oncology Inc
- Carina Biotech Pty Ltd
- Carna Biosciences Inc
- CaroGen Corp
- Carrick Therapeutics Ltd
- CAS-Lamvac Biotech Co Ltd
- Catalym GmbH
- CCRP Therapeutics GmbH
- Cell Biotech Co Ltd
- Celldex Therapeutics Inc
- Cellivery Therapeutics Inc
- Cellix Bio Pvt Ltd
- Cello Therapeutics Inc
- Celsius Therapeutics Inc
- Centrymed Pharmaceutical Inc
- CheMedImmune Inc
- Chengdu Huachuang Biotechnology Co Ltd
- Chengdu Jinrui Foundation Biotechnology Co Ltd
- Chia Tai Tianqing Pharmaceutical Group Co Ltd
- Chimeric Therapeutics Ltd
- Chimerix Inc
- China Resources Pharmaceutical Group Ltd
- Chiome Bioscience Inc
- ChoDang Pharm Co Ltd
- Chong Kun Dang Pharmaceutical Corporation
- Chongqing Precision Biotech Co Ltd
- Chugai Pharmaceutical Co Ltd
- Cinkate Corp
- Cloaked Therapeutics LLC
- CNBX Pharmaceuticals Inc
- COARE Biotechnology Inc
- Codiak BioSciences Inc
- Coherent Biopharma
- Compass Therapeutics Inc
- Compugen Ltd
- Corvus Pharmaceuticals Inc
- Cotinga Pharmaceuticals Inc
- CSPC Pharmaceutical Group Ltd
- CStone Pharmaceuticals Co Ltd
- CTCELLS Inc
- Culnexin Therapeutics LLC
- Cura Therapeutics LLC
- Curamir Therapeutics Inc
- Curegenix Inc
- Cytocraft Bio-Tech Development Co Ltd
- CytomX Therapeutics Inc
- D3 Bio Inc
- Daiichi Sankyo Co Ltd
- Deciphera Pharmaceuticals Inc
- Deka Biosciences Inc
- Delta-Fly Pharma Inc
- Denovo Biopharma LLC
- DevaCell Inc
- Dicerna Pharmaceuticals Inc
- Divide and Conquer Ltd
- DNAtrix Inc
- Dnatwo Inc
- Dragonboat Biopharmaceutical (Shanghai) Co Ltd
- Ectin Research AB
- Eden Biologics Inc
- eFFECTOR Therapeutics Inc
- Eisai Co Ltd
- Elevation Oncology Inc
- Eli Lilly and Co
- Elicio Therapeutics Inc
- Elixiron Immunotherapeutics Inc
- Ella Therapeutics Ltd
- Eloxx Pharmaceuticals Inc
- Elpiscience Biopharma Ltd
- Elucida Oncology Inc
- Eluciderm Inc
- Endeavor BioMedicines
- Enhancedbio Inc
- Ennaid Therapeutics LLC
- Enterome Bioscience SA
- EntreChem SL
- Enzo Biochem Inc
- Epizyme Inc
- Eternity Bioscience Inc
- Euclises Pharmaceuticals Inc
- Eucure (Beijing) Biopharma Co Ltd
- Eutilex Co Ltd
- Evgen Pharma Plc
- Evotec SE
- Exelixis Inc
- ExonanoRNA LLC
- F-star Therapeutics Inc
- F. Hoffmann-La Roche Ltd
- f5 Therapeutics Inc
- FasT Biopharma Ltd
- Fate Therapeutics Inc
- Fecula Biotech Corp
- Felicitex Therapeutics Inc
- Fog Pharmaceuticals Inc
- Formosa Pharmaceuticals Inc
- Forte Biosciences Inc
- Fujifilm Holdings Corp
- Fusion Pharmaceuticals Inc
- G-Cell Co Ltd
- Gadeta BV
- GAiA BioMedicine Inc
- Gbiologics Inc
- GeneCare Research Institute Co Ltd
- Genentech USA Inc
- Generos Biomedical Technology (Hangzhou) Co Ltd
- GeneScience Pharmaceuticals Co Ltd
- Genexine Inc
- GenFleet Therapeutics (Shanghai) Inc
- GenoImmune Therapeutics Biotechnology Co Ltd
- GeoVax Labs Inc
- Gilead Sciences Inc
- GLG Pharma SA
- GlycoNex Inc
- Glycostem Therapeutics BV
- Glycotope GmbH
- Gnubiotics Sciences SA
- GO Therapeutics Inc
- Gradalis Inc
- Grand Pharmaceutical Group Ltd
- Gritstone Bio Inc
- GSK plc
- GT Biopharma Inc
- Guangdong Zhongsheng Pharmaceutical Co Ltd
- Guangzhou BeBetter Medicine Technology Co Ltd
- Guangzhou Doublle Bioproduct Inc
- Handok Inc
- Hangzhou Bensheng Pharmaceutical Co Ltd
- Hangzhou DAC Biotech Co Ltd
- Hangzhou Neoantigen Therapeutics Co Ltd
- Hangzhou Zenshine Pharmaceuticals Co Ltd
- Hanmi Pharmaceuticals Co Ltd
- Harbin Gloria Pharmaceuticals Co Ltd
- Harbour BioMed (Guangzhou) Co Ltd
- Harpoon Therapeutics Inc
- HCW Biologics Inc
- HebeCell Corp
- HEC Pharma Co Ltd
- Heidelberg Pharma AG
- Helixmith Co Ltd
- Hercules Pharmaceuticals BV
- Hibercell Inc
- Hillstream BioPharma Inc
- Hookipa Pharma Inc
- Huadao Shanghai Biomedical Co Ltd
- Huahui Anjian (Beijing) Biotechnology Co Ltd
- Hubro Therapeutics AS
- Hummingbird Bioscience Pte Ltd
- Hutchison MediPharma Ltd
- iDD biotech SAS
- Ideaya Biosciences Inc
- Idera Pharmaceuticals Inc
- IGM Biosciences Inc
- Ikena Oncology Inc
- IMGENEX India Pvt Ltd
- Immix BioPharma Inc
- Immodulon Therapeutics Ltd
- Immune Biosolutions Inc
- Immuneering Corp
- ImmuneOncia Therapeutics LLC
- ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
- Immunitas Therapeutics Inc
- ImmunityBio Inc
- Immuno Cure BioTech Ltd
- Immunocore Holdings Plc
- Immunogenesis Inc
- Immunophotonics Inc
- immunoSCAPE Pte Ltd
- Immunotech Biopharm Ltd
- Immvira Co Ltd
- IMPACT Therapeutics Inc
- Imugene Ltd
- Imvax Inc
- Incanthera Plc
- Incyte Corp
- Indaptus Therapeutics Inc
- Indivumed GmbH
- Infinity Pharmaceuticals Inc
- Inhibrx Inc
- InnoCare Pharma Ltd
- InnoCure Therapeutics Inc
- Innovative Cellular Therapeutics Co Ltd
- Innovent Biologics Inc
- Inovio Pharmaceuticals Inc
- InProTher ApS
- Inspirna Inc
- Intensity Therapeutics Inc
- InteRNA Technologies BV
- Interprotein Corp
- Intezyne Inc
- Intra-Cellular Therapies Inc
- Invectys SA
- InventisBio Co Ltd
- IO Biotech Inc
- iOmx Therapeutics AG
- Ionova Life Science Co Ltd
- Iovance Biotherapeutics Inc
- Ipsen SA
- ISOThrive Inc
- ISU ABXIS Co Ltd
- Iterion Therapeutics Inc
- Jacobio Pharmaceuticals Group Co Ltd
- Jazz Pharmaceuticals Plc
- JenKem Technology Co Ltd
- Jiangsu Chia-tai Tianqing Pharmaceutical Co Ltd
- Jiangsu Hengrui Medicine Co Ltd
- Jiangsu Sinorda Biomedicine Co Ltd
- Jiangxi Jemincare Group Co Ltd
- Johnpro Biotech Inc
- Johnson & Johnson
- Joint Biosciences Ltd
- JSR Life Sciences LLC
- KAHR medical Ltd
- Karus Therapeutics Ltd
- Karyopharm Therapeutics Inc
- KeViRX Inc
- Keythera Pharmaceuticals Co Ltd
- Kezar Life Sciences Inc
- Kiadis Pharma NV
- Kineta Inc
- Kirilys Therapeutics Inc
- KLUS Pharma Inc
- Kymera Therapeutics Inc
- L&L Biopharma Co Ltd
- L.E.A.F. Pharmaceuticals LLC
- LaNova Medicines Ltd
- Lantern Pharma Inc
- Lead Discovery Center GmbH
- Leap Therapeutics Inc
- LegoChem Biosciences Inc
- Lepu Biopharma Co Ltd
- Les Laboratoires Servier SAS
- LIfT BioSciences Ltd
- Liminatus Pharma LLC
- Linnaeus Therapeutics Inc
- Locus Biosciences Inc
- Lokon Pharma AB
- Lumosa Therapeutics Co Ltd
- Luye Pharma Group Ltd
- Lyell Immunopharma Inc
- Lytix Biopharma AS
- Mabpharm Ltd
- MacroGenics Inc
- MAIA Biotechnology Inc
- Malachite Innovations Inc
- Mantis Therapeutics BV
- Marino Biotechnology Co Ltd
- Maverick Therapeutics Inc
- MD Healthcare Inc
- MD2 Biosciences Inc
- MdBioLab
- MedAnnex Ltd
- MedBiome Inc
- Medesis Pharma SA
- MediaPharma SRL
- Medicenna Therapeutics Corp
- MediciNova Inc
- Medigen Biotechnology Corp
- MEI Pharma Inc
- Mekanistic Therapeutics LLC
- Merck & Co Inc
- Merck KGaA
- Mereo Biopharma Group Plc
- Merus NV
- Metagone Biotech Inc
- Millennium Pharmaceuticals Inc
- Mirati Therapeutics Inc
- Mitsubishi Tanabe Pharma Corp
- Moderna Inc
- Molecular Partners AG
- Molecular Templates Inc
- Mologen AG
- Morphogenesis Inc
- Multimmune GmbH
- Multitude therapeutics Inc
- Nanjing KAEDI Biotech Inc
- NantBioScience Inc
- Navire Pharma Inc
- NEOGAP Therapeutics AB
- New Beta Innovation Ltd
- NewG Lab Pharma Inc
- NEX-I Inc
- NextCure Inc
- NGM Biopharmaceuticals Inc
- NH TherAguix SAS
- Nimbus Therapeutics LLC
- Nitto BioPharma Inc
- Novartis AG
- Nuvalent Inc
- OBI Pharma Inc
- Oblique Therapeutics AB
- Oceanyx Pharmaceuticals Inc
- Omideon Ltd
- Oncoinvent AS
- Oncology Research International Ltd
- Oncomatryx Biopharma SL
- Onconic Therapeutics Co Ltd
- Onconova Therapeutics Inc
- OncoOne Research & Development GmbH
- Oncostellae SL
- Oncotelic Therapeutics Inc
- Oncovir Inc
- OnKure Inc
- Ono Pharmaceutical Co Ltd
- Onxeo SA
- Opna Bio SA
- Orano Med LLC
- Orion Biotechnology Canada Ltd
- Orum Therapeutics Inc
- Oxford BioTherapeutics Ltd
- Oxford Drug Design Ltd
- P&PMed Shanghai Biotechnology Co Ltd
- Pacific Meniuoke Biopharmaceutical Company
- Pact Pharma Inc
- Pacylex Pharmaceuticals Inc
- Palleon Pharmaceuticals Inc
- Panbela Therapeutics Inc
- Parasol Biotech Co Ltd
- Pasithea Therapeutics Corp
- PDS Biotechnology Corp
- Penrose Therapeutix LLC
- Peptomyc SL
- Perseus Proteomics Inc
- PersonGen BioTherapeutics (Suzhou) Co Ltd
- Pfizer Inc
- Pharma Mar SA
- PharmAbcine Inc
- Pharos iBio Co Ltd
- Phi Pharma SA
- Phio Pharmaceuticals Corp
- Phision Therapeutics
- Pieris Pharmaceuticals Inc
- Pionyr Immunotherapeutics Inc
- Plexxikon Inc
- POINT Biopharma Global Inc
- Polaris Pharmaceuticals Inc
- Portage Biotech Inc
- Poseida Therapeutics Inc
- Potenza Therapeutics Inc
- Precision Biologics Inc
- Prescient Therapeutics Ltd
- PRISM Pharma Co Ltd
- Privo Technologies Inc
- Promontory Therapeutics Inc
- Propanc Biopharma Inc
- Protheragen Inc
- Provectus Biopharmaceuticals Inc
- PsiOxus Therapeutics Ltd
- Psivac Ltd
- Pure Biologics SA
- Purple Biotech Ltd
- Qilu Pharmaceutical Co Ltd
- QLSF Biotherapeutics Inc
- Qu Biologics Inc
- Quadriga BioSciences Inc
- Qualigen Therapeutics Inc
- R-Pharm
- RadBio
- Radiopharm Theranostics Ltd
- Radiopharm Ventures LLC
- RaQualia Pharma Inc
- Recursion Pharmaceuticals Inc
- RedHill Biopharma Ltd
- Regeneron Pharmaceuticals Inc
- Replimune Ltd
- Res Nova Bio Inc
- Resonant Therapeutics Inc
- Reven Holdings Inc
- Revere Pharmaceuticals Inc
- Revolution Medicines Inc
- RhemaStem SRLS
- Rhizen Pharmaceuticals SA
- Rizen (Suzhou) Biosciences Co Ltd
- Roivant Sciences Inc
- Rophibio Inc
- Roquefort Therapeutics Plc
- Ryvu Therapeutics SA
- Sagimet Biosciences Inc
- Salarius Pharmaceuticals Inc
- Salix Pharmaceuticals Ltd
- Samjin Pharm Co Ltd
- Sanofi
- Sapience Therapeutics Inc
- Sareum Holdings Plc
- Scancell Holdings Plc
- Scandion Oncology AS
- Schrodinger Inc
- Score Pharma Inc
- Seagen Inc
- Secarna Pharmaceuticals GmbH & Co KG
- Second Genome Inc
- Secura Bio Inc
- Senda Biosciences Inc
- Senti Biosciences Inc
- Seven and Eight Biopharmaceuticals Corp
- Shandong Luye Pharmaceutical Co Ltd
- Shanghai Bioray Laboratory Inc
- Shanghai Cell Therapy Group Co
- Shanghai De Novo Pharmatech Co Ltd
- Shanghai Escugen Biotechnology Co Ltd
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
- Shanghai Gefeimu Biomedical Technology Co Ltd
- Shanghai GeneChem Co Ltd
- Shanghai Haihe Biopharma Co Ltd
- Shanghai Haishi Biopharmaceutical Co Ltd
- Shanghai Haiyan Pharmaceutical Technology Co Ltd
- Shanghai HyaMab Biotech Co Ltd
- Shanghai Junshi Bioscience Co Ltd
- Shanghai Keqi Pharmaceutical Technology Co Ltd
- Shanghai Sailun Biotechnology Co Ltd
- Shanghai Xunhe Pharmaceutical Technology Co Ltd
- Shanghai Yihao Biotechnology Co Ltd
- Shenzhen Chipscreen Biosciences Co Ltd
- Shenzhen Fapon Biopharma Inc
- Shijiazhuang Sagacity New Drug Development Co Ltd
- Sichuan Huiyang Life Science and Technology Corp
- Sichuan Kelun Pharmaceutical Co Ltd
- SignalChem Lifesciences Corp
- Sihuan Pharmaceutical Holdings Group Ltd
- Simcere Pharmaceutical Group Ltd
- Singh Biotechnology LLC
- Sino Biopharmaceutical Ltd
- SinoCelltech Group Ltd
- SiNOPSEE Therapeutics Pte Ltd
- siRNAgen Therapeutics Corp
- Sirnaomics Ltd
- SiVEC Biotechnologies LLC
- SN BioScience
- Sorrento Therapeutics Inc
- Sosei Group Corp
- SOTIO Biotech AS
- Spago Nanomedical AB
- SpringWorks Therapeutics Inc
- ST Pharm Co Ltd
- Starpharma Holdings Ltd
- Statera Biopharma Inc
- STC Biologics Inc
- Stcube Inc
- StemGen SpA
- Stemirna Therapeutics Ltd
- Stemsynergy Therapeutics Inc
- Stingthera Inc
- Sumitomo Dainippon Pharma Oncology, Inc
- Sumitomo Pharma Co Ltd
- SuviCa Inc
- Suzhou Dingfu Target Biotechnology Co Ltd
- Suzhou GenHouse Pharmaceutical Co Ltd
- Suzhou Zanrong Pharmaceutical Technology Co Ltd
- Suzhou Zelgen Biopharmaceutical Co Ltd
- Suzhou Zerun New Drug Research and Development Co Ltd
- Syncromune Inc
- Syndivia SAS
- Syntekabio Inc
- Syros Pharmaceuticals Inc
- Systimmune Inc
- Tagworks Pharmaceuticals BV
- Taiho Oncology Inc
- Taiho Pharmaceutical Co Ltd
- Tailored Therapeutics LLC
- Takeda Pharmaceutical Co Ltd
- Targovax ASA
- Tarrex Biopharma Ltd
- Tarveda Therapeutics Inc
- Tasly Pharmaceutical Group Co Ltd
- TCR2 Therapeutics Inc
- Teclison Ltd
- Tempest Therapeutics Inc
- Tengji (Xiamen) Biomedical Technology Co Ltd
- Teon Therapeutics Inc
- Tessa Therapeutics Ltd
- Theolytics Ltd
- TheraBioPharma Inc
- Theratechnologies Inc
- Theravectys SA
- Tonix Pharmaceuticals Holding Corp
- Topadur Pharma AG
- Toray Industries Inc
- Totus Medicines Inc
- TRACON Pharmaceuticals Inc
- Transgene SA
- Triumvira Immunologics Inc
- Turning Point Therapeutics Inc
- Tvardi Therapeutics Inc
- Tyme Inc
- UBI Pharma Inc
- UCB SA
- United BioPharma Inc
- UWELL Biopharma Inc
- VasGene Therapeutics Inc
- Vaxil Bio Therapeutics Ltd
- Vaximm AG
- Venn Therapeutics LLC
- Verastem Inc
- Vidac Pharma
- Vincerx Pharma Inc
- Virocure Inc
- Vivacitas Oncology Inc
- VREX Therapeutics Inc
- VS Pharmtech Co Ltd
- WellMarker Bio Co Ltd
- Western Oncolytics Ltd (Inactive)
- WntResearch AB
- Wuhan YZY Biopharma Co Ltd
- Xbrane Biopharma AB
- XEME BioPharma Inc
- Xencor Inc
- Xiangxue Life Sciences
- XuanZhu Biological Technology Co Ltd
- Xynomic Pharmaceuticals Holdings Inc
- Yangtze River Pharmaceutical Group
- Yisheng Biopharma Co Ltd
- Yukin Therapeutics SAS
- Zelluna Immunotherapy AS
- Zhejiang Teruisi Pharmaceutical Co Ltd
- Zhejiang Yangshengtang Biotech Co Ltd
- Zymeworks Inc
